|
| |
| | | 69497 | | 11.10.2024 | | Teva Pharma AG | | | | | | | 10.10.2029 | | | | | | | | | | 07.16.40. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Pomalidomid-Teva Mepha 1 mg | Hartkapseln | Capsules ( 1 mg) | L04AX06 | | | 02 | Pomalidomid-Teva Mepha 2 mg | Hartkapseln | Capsules ( 2 mg) | L04AX06 | | | 03 | Pomalidomid-Teva Mepha 3 mg | Hartkapseln | Capsules ( 3 mg) | L04AX06 | | | 04 | Pomalidomid-Teva Mepha 4 mg | Hartkapseln | Capsules ( 4 mg) | L04AX06 | |
|
|
|
